S
Sanara Medtech Inc (SMTI)
Official siteHEALTHCARE • MEDICAL INSTRUMENTS & SUPPLIES • NASDAQ
$32.76
+0.41 (+1.27%)
Market Cap: $297.06M
Last updated: Nov 17, 2026 at 11:02 AM ET
Sanara Medtech Inc (SMTI) Valuation Multiples
Sanara Medtech (SMTI) trades at 2.6x sales and 37.5x book value. Its P/S of 2.6x is below its 5-year median of 3.9x. Its forward P/E is 217.4x.
Current Multiples
Its enterprise value is 22.1x its EBITDA.
| Multiple | Value |
|---|---|
| P/E (trailing) | N/A |
| Forward P/E | 217.4x |
| Price to sales | 2.6x |
| Price to book | 37.5x |
| EV/EBITDA | 22.1x |
| PEG | N/A |
Historical Medians
| Multiple | Current | 5-year median | 10-year median |
|---|---|---|---|
| P/S | 2.6x | 3.9x | N/A |
| P/B | 37.5x | 7.3x | N/A |
Valuation History
Over the 7 of the 10 year ends shown that have a P/S, its P/S ranged from 1.8x in 2019 to 18.6x in 2020.
| Year end | Price | P/E | P/S | P/B |
|---|---|---|---|---|
| 2025 | $23.35 | N/A | 2.0x | 34.0x |
| 2024 | $33.20 | N/A | 3.3x | 7.2x |
| 2023 | $41.10 | N/A | 5.3x | 7.8x |
| 2022 | $45.50 | N/A | 8.0x | 9.0x |
| 2021 | $29.55 | N/A | 9.0x | 7.3x |
| 2020 | $49.90 | N/A | 18.6x | 50.5x |
| 2019 | $16.10 | N/A | 1.8x | 15.2x |
| 2018 | $3.27 | 75.3x | N/A | 4.9x |
| 2017 | $6.00 | 201.3x | N/A | N/A |
| 2016 | $3.79 | N/A | N/A | N/A |
Frequently Asked Questions About SMTI
What is SMTI's forward P/E ratio?
Sanara Medtech has a forward P/E ratio of 217.4x.
What is SMTI's price to sales ratio?
Sanara Medtech has a price to sales ratio of 2.6x.
SMTI pages: Overview, Earnings, Forecast, Financials, Valuation, Competitors